CA1154755A - Cholesterol derivatives - Google Patents

Cholesterol derivatives

Info

Publication number
CA1154755A
CA1154755A CA000352892A CA352892A CA1154755A CA 1154755 A CA1154755 A CA 1154755A CA 000352892 A CA000352892 A CA 000352892A CA 352892 A CA352892 A CA 352892A CA 1154755 A CA1154755 A CA 1154755A
Authority
CA
Canada
Prior art keywords
acid
organic dibasic
dibasic acid
ketocholesterol
half ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000352892A
Other languages
English (en)
French (fr)
Inventor
Yoshio Arakawa
Yahiro Uemura
Atuyuki Takanabe
Daisuke Satoh
Satoshi Funakoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Application granted granted Critical
Publication of CA1154755A publication Critical patent/CA1154755A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CA000352892A 1979-06-20 1980-05-28 Cholesterol derivatives Expired CA1154755A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7676779A JPS563000A (en) 1979-06-20 1979-06-20 Water-soluble cholesterol derivative
JP76767/79 1979-06-20

Publications (1)

Publication Number Publication Date
CA1154755A true CA1154755A (en) 1983-10-04

Family

ID=13614739

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000352892A Expired CA1154755A (en) 1979-06-20 1980-05-28 Cholesterol derivatives

Country Status (7)

Country Link
US (1) US4304726A (OSRAM)
JP (1) JPS563000A (OSRAM)
CA (1) CA1154755A (OSRAM)
DE (1) DE3022788C2 (OSRAM)
FR (1) FR2459248A1 (OSRAM)
GB (1) GB2053924B (OSRAM)
SE (1) SE445833B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3174870D1 (en) * 1981-03-13 1986-07-31 Green Cross Corp Water-soluble cholesterol derivatives
JPS60258198A (ja) * 1984-06-04 1985-12-20 Amano Pharmaceut Co Ltd トリテルペンアルコ−ル有機酸エステル及びその製造法
DE3803757A1 (de) * 1988-02-08 1989-08-17 Boehringer Mannheim Gmbh Cholesterin-esterase-farbsubstrat
US5496806A (en) * 1990-01-23 1996-03-05 R. Erich Klemke Glycoside compounds and production and use thereof
FI974648A7 (fi) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö
KR20020028876A (ko) 1999-04-30 2002-04-17 추후제출 스테로이드 유도체
WO2002062302A2 (en) * 2001-02-08 2002-08-15 The University Of Chicago Steroidal derivatives
CA2446314C (en) * 2001-05-03 2011-02-22 The University Of Chicago Liver x receptor agonists
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
JP4272518B2 (ja) * 2001-09-07 2009-06-03 栄次 松浦 β２−グリコプロテインＩに対するリガンド及びその用途
AU2003228485A1 (en) * 2002-04-12 2003-10-27 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
US20100048912A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
AU2010210422A1 (en) * 2009-02-05 2011-08-18 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
JP2013500986A (ja) * 2009-07-29 2013-01-10 ザ・ユニバーシティ・オブ・シカゴ 肝臓ｘ受容体アゴニスト
EP2522350B1 (de) * 2011-05-12 2013-07-31 Immunopharm AG Verwendung der Wirkstoffkombination aus einem 1-Diethylaminoethyl-3-Chinoxalin-2-on Derivat und einem Oxysterol zur Durchbrechung von Resistenzen bei der Behandlung von Krebs und zur Erhöhung der Immunleistungsfähigkeit bei Krebs, bakteriellen und viralen Erkrankungen, Autoimmunerkrankungen, erhöhter Stress- und Umweltbelastung
EP4066841A1 (en) 2013-03-14 2022-10-05 University of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1224738B (de) * 1960-12-29 1966-09-15 Takeda Chemical Industries Ltd Verfahren zur Herstellung von Cholestan-3, 5, 6-triol-3-estern oder -3, 6-diestern soowie von deren Salzen
GB1553540A (en) * 1977-02-23 1979-09-26 Green Cross Corp Medicaments containing cholesterol derivatives
US4202891A (en) * 1977-05-16 1980-05-13 Kandutsch Andrew A 15-Oxygenated sterol compounds and the use of such compounds to inhibit the biosynthesis of sterols
US4189400A (en) * 1977-08-17 1980-02-19 Bonderman Dean P Compound useful in cholesterol assay procedures
US4225525A (en) * 1979-02-08 1980-09-30 Hoffmann-La Roche Inc. Vitamin D3 metabolite derivatives

Also Published As

Publication number Publication date
JPS563000A (en) 1981-01-13
SE445833B (sv) 1986-07-21
FR2459248A1 (fr) 1981-01-09
US4304726A (en) 1981-12-08
GB2053924A (en) 1981-02-11
DE3022788C2 (de) 1982-08-12
GB2053924B (en) 1983-04-27
FR2459248B1 (OSRAM) 1983-10-28
SE8004125L (sv) 1980-12-21
DE3022788A1 (de) 1981-01-08

Similar Documents

Publication Publication Date Title
CA1154755A (en) Cholesterol derivatives
DE4141746A1 (de) 20-methyl-substituierte vitamin d-derivate
US4251520A (en) Glucofuranose derivatives
AT395853B (de) Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
DE2856753A1 (de) N-substituierte omega -aminoalkanoyl- omega -aminoalkansaeuren, ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
GB1599863A (en) Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid
US3903137A (en) Choline sulfonate derivatives
DE2643936A1 (de) Arzneimittel mit erythropoietischer wirksamkeit
DE2455353B2 (de) Substituierte a -Aminooxycarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung und Verfahren zur Herstellung derselben
GB2041219A (en) Topical pharmaceutical compositions containing thiazolidine-substituted corticosteroids
DE3132221A1 (de) Neue cyclophosphamid-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE2557145C3 (de) Tyrosinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0073834B1 (en) Water-soluble cholesterol derivatives
EP0009777A1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0013891B1 (de) Dipeptide zur Verwendung bei der Heilung von Krankheiten, einige neue Stoffe aus dieser Verbindungsgruppe, Dipeptide enthaltende Arzneimittel und deren Herstellung
EP1185510B1 (de) S-nitroso- und s-nitro-n-acyl-l-cystein-ester-derivate als pharmakologische wirkstoffe und diese verbindungen enthaltende arzneimittel
KR830002844B1 (ko) 수용성 콜레스테롤 유도체의 제조방법
JPS61293993A (ja) 新規な螢光物質，その製造方法及び薬剤
JPH0772157B2 (ja) ベンジルアルコール誘導体及びこれを有効成分とするｐｇｅ２産生抑制剤並びにｎｇｆ産生誘導剤
SE448166B (sv) Derivat av 11-desoxi-17alfa-hydroxikortikosteron
Bodor et al. Improved delivery through biological membranes. XII. The effect of the incorporation of biphasic solubilizing groups into prodrugs of steroids
JPS58116459A (ja) トリヒドロキシビタミンｄ↓３化合物
JPS5829318B2 (ja) プロスタグランジンルイジカゴウブツ ホウホウ
EP0100983A1 (en) Steroid compounds with choleretic activity, a process for their preparation, and therapeutic compounds which contain them as active principle
EP0357092B1 (en) Preparation of diacetoxybenzylidene diacetates

Legal Events

Date Code Title Description
MKEX Expiry